Compile Data Set for Download or QSAR
Report error Found 3160 with Last Name = 'jiang' and Initial = 'z'
TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632630(US20230348450, Example 3)
Affinity DataEC50:  0.320nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632632(US20230348450, Example 209 | US20230348450, Exampl...)
Affinity DataEC50:  0.0680nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632633(US20230348450, Example 6)
Affinity DataEC50:  0.110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632634(US20230348450, Example 7)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632635(US20230348450, Example 8)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632636(US20230348450, Example 9)
Affinity DataEC50:  0.460nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632637(US20230348450, Example 10)
Affinity DataEC50:  0.175nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632630(US20230348450, Example 3)
Affinity DataEC50:  320nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632631(US20230348450, Example 4)
Affinity DataEC50:  180nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632632(US20230348450, Example 209 | US20230348450, Exampl...)
Affinity DataEC50:  57nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632633(US20230348450, Example 6)
Affinity DataEC50:  110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632634(US20230348450, Example 7)
Affinity DataEC50:  60nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632635(US20230348450, Example 8)
Affinity DataEC50:  60nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632636(US20230348450, Example 9)
Affinity DataEC50:  460nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632637(US20230348450, Example 10)
Affinity DataEC50:  160nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632669(US20230348450, Example 49)
Affinity DataEC50:  520nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632670(US20230348450, Example 50)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632671(US20230348450, Example 51)
Affinity DataEC50:  4.30E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632672(US20230348450, Example 52)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632682(US20230348450, Example 63)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632684(US20230348450, Example 65)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632685(US20230348450, Example 66)
Affinity DataEC50:  110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632686(US20230348450, Example 67)
Affinity DataEC50:  550nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632687(US20230348450, Example 68)
Affinity DataEC50:  60nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632690(US20230348450, Example 71)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632691(US20230348450, Example 72)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632692(US20230348450, Example 73)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632693(US20230348450, Example 74)
Affinity DataEC50:  1.10E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632694(US20230348450, Example 75)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632695(US20230348450, Example 76)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632697(US20230348450, Example 78)
Affinity DataEC50:  70nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632698(US20230348450, Example 79)
Affinity DataEC50:  110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632699(US20230348450, Example 80)
Affinity DataEC50:  1.70E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632700(US20230348450, Example 81)
Affinity DataEC50:  1.10E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632701(US20230348450, Example 82)
Affinity DataEC50:  210nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632702(US20230348450, Example 83)
Affinity DataEC50:  1.40E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632705(US20230348450, Example 86)
Affinity DataEC50:  200nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632706(US20230348450, Example 87)
Affinity DataEC50:  8.70E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632707(US20230348450, Example 88)
Affinity DataEC50:  1.20E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632712(US20230348450, Example 93)
Affinity DataEC50:  270nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632713(US20230348450, Example 94)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632714(US20230348450, Example 95)
Affinity DataEC50:  2.10E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632715(US20230348450, Example 96)
Affinity DataEC50:  10nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632716(US20230348450, Example 97)
Affinity DataEC50:  160nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632717(US20230348450, Example 98)
Affinity DataEC50:  100nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632718(US20230348450, Example 99)
Affinity DataEC50:  280nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632719(US20230348450, Example 100)
Affinity DataEC50:  420nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632720(US20230348450, Example 101)
Affinity DataEC50:  7.30E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632721(US20230348450, Example 102)
Affinity DataEC50:  360nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632722(US20230348450, Example 103)
Affinity DataEC50:  130nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 3160 total ) | Next | Last >>
Jump to: